PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2015
CASE
Bristol-Myers Squibb Pharmaceuticals

Pfizer and Bristol-Myers Squibb: restaurant speaker meetings and concerns about privacy and hospitality (no breach)

Anonymous complaint about two restaurant-based promotional speaker meetings alleged public could overhear and hospitality was excessive. Panel found complainant did not prove…

2008
CASE
AUTH/2122/5/08 Bayer

AUTH/2122/5/08: Anonymous ex-employee v Bayer Schering Pharma – Nebido advertisement (no breach)

An ex-employee alleged a Nebido BMJ ad implied men would become attractive to younger women (unlicensed). The Panel found the imagery reflected…

2008
CASE
Pfizer ⭐ Case of the Week

Pfizer Lipitor journal advertisement found misleading for exaggerating urgency to prescribe

A GP challenged a Lipitor journal ad using a fireman analogy. The Panel and Appeal Board found it misleading for exaggerating urgency…

2008
CASE
AUTH/2146/7/08 Sanofi

Sanofi-Aventis: Plavix promotion misleadingly linked REACH registry to Plavix use (AUTH/2146/7/08)

A primary care trust chief pharmacist complained that a representative and materials implied the REACH registry supported Plavix use. The Panel ruled…

2008
CASE
AUTH/2138/7/08 Reckitt Benckiser Healthcare

AUTH/2138/7/08: In-vitro BMJ advertisements for Gaviscon Advance found misleading due to implied in-vivo/clinical claims

Two BMJ advertisements for Gaviscon Advance used in-vitro data but implied in-vivo/clinical oesophageal protection and wider clinical benefit. The Panel ruled both…

2008
CASE
Takeda

GSK v Takeda Europe: Actos (pioglitazone) Diabetologia ad and cardiovascular safety claims

A Diabetologia journal ad for Actos claimed β€œno long-term cardiovascular concerns” without adequately reflecting SPC qualifications and heart failure warnings. The Panel…

2009
CASE
AUTH/2203/1/09 Pfizer

AUTH/2203/1/09: Johnson & Johnson v Pfizer – Champix journal advertisement claim vs NRT ruled misleading

A Champix journal ad claimed significantly greater quit success vs NiQuitin CQ Clear at 12 weeks. The Panel ruled the claim misleading…

2008
CASE
AUTH/2195/12/08 Otsuka ⭐ Case of the Week

AUTH/2195/12/08: General Practitioner v Otsuka – Representative email to practice manager (conduct and disparaging comments)

A GP practice complained about an Otsuka representative’s unprofessional email (sent from work email) containing disparaging comments about GPs. Breaches were found…

2008
CASE
AUTH/2185/11/08 Schering-Plough

Schering-Plough: NeoClarityn β€˜triple stopping power’ ad misleading on β€˜anti-inflammatory’ claim (AUTH/2185/11/08)

A NeoClarityn journal ad implied clinically supported β€˜anti-inflammatory’ action. PMCPA found it inconsistent with the SPC and misleading, breaching Clauses 3.2 and…

2008
CASE
AUTH/2170/9/08 Syner-Med

AUTH/2170/9/08: Syner-Med Ferinject brochure – misleading CosmoFer infusion time (Clause 7.2)

A nurse complained a Ferinject brochure implied CosmoFer required a 6-hour infusion, causing anxiety about correct administration. Panel relied on an earlier…

2009
CASE
AUTH/2264/9/09 GlaxoSmithKline

GSK satellite symposium invitation at ESC 2009: not disguised promotion, but missing prescribing information (AUTH/2264/9/09)

GSK’s ESC 2009 symposium invite was held not to be disguised promotion, but because it referenced ambrisentan it was promotional and needed…

2009
CASE
AUTH/2241/6/09 Eli Lilly

AUTH/2241/6/09: Consultants in Child and Adolescent Psychiatry v Lilly (Strattera Support Service) – No breach

Consultants alleged Lilly’s Strattera Support Service meant company staff contacted patients and could give biased advice. Panel found contact was via independent…

2009
CASE
AUTH/2220/3/09 Eli Lilly ⭐ Case of the Week

Anonymous v Lilly (AUTH/2220/3/09): Promotional content embedded in β€œindependent” diabetes course and excessive 1:1 meetings with consultant

Lilly was found in breach after a branded promotional presentation appeared to be part of a university diabetes course, and for an…

2009
CASE
AUTH/2267/9/09 Gamble

Shire v Procter & Gamble: Asacol strapline β€œconfidence in colitis” ruled inconsistent with SPC; unqualified HCP quote on switching also misleading (AUTH/2267/9/09)

P&G’s Asacol materials used β€œconfidence in colitis” without clear qualification, implying use across all colitis types (breach 3.2). A leavepiece also used…

2009
CASE
AUTH/2262/9/09 Pfizer

AUTH/2262/9/09: Media/Director v Pfizer β€” Celebrex study recruitment meeting at five-star hotel (No breach on appeal)

BMJ criticised a five-star GP recruitment meeting for a Pfizer-funded celecoxib safety study and lack of funding disclosure. Panel found breaches, but…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training